PROGRAM

Program by date

Time slot's time in Taipei (GMT+8)


Plenary Session I-2024/11/23

201 BCDE

Emerging Biomarkers and Treatment for Parkinson’s Disease

  • Time
  • Topic
  • Speaker
  • Moderator
  • 08:30-09:10
  • Plasma-based biomarkers for risk and progression of Parkinson’s disease
  • Speaker:  Taku  Hatano
    (Japan)
  • Moderator: 
  • 09:10-09:50
  • From biomarkers to precision medicine for Parkinson’s disease
  • Speaker:  Chin-Hsien  Lin
    (Taiwan)
  • Moderator: 
  • 09:50-10:10
  • Coffee Break
  • Speaker: 
  • Moderator: 
  • 10:10-10:50
  • Mechanism-targeted molecular and gene therapy for Parkinson’s disease
  • Speaker:  Lorraine  Kalia
    (Canada)
  • Moderator: 
  • 10:50-11:30
  • Antibody-based therapies in Parkinson's disease: reality and hopes
  • Speaker:  Tiago  Outeiro
    (Germany)
  • Moderator: 

Plenary Session II-2024/11/23

201 BCDE

Meetup with the Experts for Being a Good Clinician and Researcher

  • 11:40-12:50
  • Pannel Jon Stoessl Victor Fung Shen-Yang Lim
  • Speaker: 
  • Moderator: 
  • 11:40-12:50
  • Discusser Yen-Yu Lo Chin-Hsien Lin Yih-Ru Wu
  • Speaker: 
  • Moderator: 
  • 13:00-13:50
  • Luncheon Symposium in venue 102, or North Lunge 3F, or South Lounge 3F
  • Speaker: 
  • Moderator: 

Parallel Session I-2024/11/23

201 BC

Exploring the Pathogenesis of Parkinson’s Disease in Basic Science

  • Time
  • Topic
  • Speaker
  • Moderator
  • 14:00-14:30
  • How gut microbiota modulate the host movement via GLP-1?
  • Speaker:  Wei-Li  Wu
    (Taiwan)
  • Moderator: 
  • 14:30-15:00
  • Protein-based dyshomeostasis in Parkinson’s disease
  • Speaker:  Lorraine  Kalia
    (Canada)
  • Moderator: 
  • 15:00-15:30
  • From proteinopathy to lipidopathy: understanding synucleinopathies
  • Speaker:  Tiago  Outeiro
    (Germany)
  • Moderator: 

Parallel Session IV -2024/11/23

201 BC

Advancing Translational Application of the Molecular Mechanisms in Four-Repeat Tauopathies

  • Time
  • Topic
  • Speaker
  • Moderator
  • 16:00-16:30
  • The diversity of clinical features and biomarkers of progressive supranuclear palsy
  • Speaker:  Shen-Yang  Lim
    (Malaysia)
  • Moderator: 
  • 16:30-17:00
  • The application of Tau PET and related biomarkers in 4R tauopathy parkinsonism syndrome
  • Speaker:  Cheng-Hsuan  Li
    (Taiwan)
  • Moderator: 
  • 17:00-17:30
  • Anti-sense oligonucleotide therapy for tauopathy disorders
  • Speaker:  Don  Cleveland
    (United States)
  • Moderator: 
  • 18:00-21:30
  • Gala Dinner and Video Challenges in 3F Banquet Hall
  • Speaker: 
  • Moderator: 

Parallel Session II-2024/11/23

201 DE

Moving Forward New Horizons of Neurophysiology in Movement Disorders

  • Time
  • Topic
  • Speaker
  • Moderator
  • 14:00-14:30
  • Deep brain stimulation for dystonia
  • Speaker:  Suneil  Kalia
    (Canada)
  • Moderator: 
  • 14:30-15:00
  • Electrophysiological and bioengineering techniques in movement disorders: new insights for diagnosis and treatment
  • Speaker:  Kendall H  Lee
    (United States)
  • Moderator: 
  • 15:00-15:30
  • Clinical application of TMS-EEG in movement disorders
  • Speaker:  Po-Yu  Fong
    (Taiwan)
  • Moderator: 

Parallel Session V-2024/11/23

201 DE

Unravelling Unmet Needs of Therapy for Movement Disorders: Where Are We?

  • Time
  • Topic
  • Speaker
  • Moderator
  • 16:00-16:30
  • Management of the key non-motor symptoms in Parkinson’s disease
  • Speaker:  Han-Lin  Chiang
    (Taiwan)
  • Moderator: 
  • 16:30-17:00
  • Cerebellar neuromodulation in severe essential tremor: Does dual-stimulation paly a promising role?
  • Speaker:  Marie  Vidailhet
    (France)
  • Moderator: 
  • 17:00-17:30
  • Quantitative analysis of movement disorders with neurophysiology methods
  • Speaker:  Jui-Cheng  Chen
    (Taiwan)
  • Moderator: 
  • 18:00-21:30
  • Gala Dinner and Video Challenges in 3F Banquet Hall
  • Speaker: 
  • Moderator: 
The words and digits in red color indicate waiting for confirmation or finalization

Parallel Session III-2024/11/23

102

Challenges and Promise: Expanding Frontier of Movement Disorders by Neuroimaging

  • Time
  • Topic
  • Speaker
  • Moderator
  • 14:00-14:30
  • Emerging advanced diffusion MRI techniques applied to Parkinson’s disease and atypical parkinsonism
  • Speaker:  Yao-Chia  Shih
    (Taiwan)
  • Moderator: 
  • 14:30-15:00
  • Evidence of functional magnetic resonance imaging in pathophysiology of freezing of gait in Parkinson’s disease
  • Speaker:  Jeng-Ren  Duann
    (Taiwan)
  • Moderator: 
  • 15:00-15:30
  • pdates of neuroimaging tools for Parkinson’s disease
  • Speaker:  Jon  Stoessl
    (Canada)
  • Moderator: 

Parallel Session VI-2024/11/23

102

Pearls and Oysters: Casement Window for Movement Disorders in Clinical Practice

  • Time
  • Topic
  • Speaker
  • Moderator
  • 16:00-16:30
  • Prodromal stage of MSA: early identification for better therapeutic plans?
  • Speaker:  Han-Joon  Kim
    (Korea,South)
  • Moderator: 
  • 16:30-17:00
  • What do eye movements tell us about patients with movement disorders?
  • Speaker:  Tim  Anderson
    (New Zealand)
  • Moderator: 
  • 17:00-17:30
  • Cerebellar syndromes induced by treatable causes: diagnoses not to miss
  • Speaker:  Pramod  Pal
    (India)
  • Moderator: 
  • 18:00-21:30
  • Gala Dinner and Video Challenges in 3F Banquet Hall
  • Speaker: 
  • Moderator: 
The words and digits in red color indicate waiting for confirmation or finalization